Brain Imaging Devices Market Report: Market Size & Forecast 2026

The Brain Imaging Devices Market comprises a range of non-invasive diagnostic technologies used to capture detailed images of brain anatomy, physiology, and activity. The market spans multiple modalities including magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT), functional near-infrared spectroscopy (fNIRS), electroencephalography (EEG), and magnetoencephalography (MEG). With a global valuation of approximately $7.29 billion in 2025, the sector reflects sustained demand from hospitals, diagnostic imaging centers, research institutions, and pharmaceutical companies.

• •Primary modalities include MRI (structural and functional), PET, CT, EEG, and emerging portable neuroimaging devices
• •Major end users are hospitals, specialty clinics, academic research centers, and pharmaceutical firms conducting clinical trials
• •Market growth is supported by rising global healthcare expenditure and expanding indications for neuroimaging beyond traditional diagnostics

The market's expansion is primarily fueled by the escalating global burden of neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and traumatic brain injuries. An aging demographic profile in developed and developing nations amplifies the incidence of neurodegenerative conditions requiring advanced imaging for diagnosis and monitoring. Additionally, technological innovations such as ultra-high-field MRI (7T and above), AI-powered image analysis, and hybrid PET/MR systems enhance diagnostic accuracy and expand clinical applications.

• •Rising prevalence of neurodegenerative diseases and neurological disorders globally drives sustained demand for advanced imaging
• •Technological advancements including AI-assisted diagnostics, higher-field MRI, and hybrid imaging systems improve clinical utility
• •Increasing pharmaceutical R&D spending and the need for neuroimaging in clinical drug trials accelerate adoption

The market is segmented by product type, technology, end user, and geography. Product categories span MR Systems, PET Scanners, CT Scanners, and Other Devices (EEG, MEG, fNIRS), with MRI holding the largest share due to its superior soft-tissue contrast and absence of ionizing radiation. Geographically, North America leads the market, supported by advanced healthcare infrastructure, high disease prevalence, and favorable reimbursement policies. The Asia-Pacific region is expected to register the fastest growth, propelled by improving healthcare access, rising medical tourism, and increasing investments in healthcare infrastructure across countries such as China, India, and Japan.

• •North America commands the largest regional share, with the United States representing a dominant sub-market due to high adoption rates and robust R&D activity
• •Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, growing patient populations, and rising disposable incomes
• •Europe maintains a strong position, particularly in Western Europe, supported by established healthcare systems and active research communities

What are the recent trends and outlook?

Looking forward, the brain imaging devices market is expected to maintain steady growth through 2032 and beyond, supported by continued innovation in imaging hardware, the integration of artificial intelligence and machine learning for automated image interpretation, and the development of compact, more affordable systems. AI and deep learning algorithms are increasingly embedded in imaging platforms to enhance diagnostic speed and accuracy, reduce radiologist workload, and enable earlier detection of neurological conditions. The growing emphasis on personalized medicine and precision neurology, combined with expanding research into brain-computer interfaces and neurostimulation therapies, is likely to create new application areas and revenue streams.

• •AI and machine learning integration into imaging software for automated diagnosis, image reconstruction, and predictive analytics represents a key technological trend
• •Development of portable, point-of-care neuroimaging devices and wearable EEG systems is expanding access beyond traditional hospital settings
• •Advances in hybrid imaging (PET/MR, SPECT/CT) and molecular imaging techniques are broadening applications in neurology, oncology, and psychiatric research